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Objective: To prospectively evaluate the heterogeneous appearance of the thyroid gland, reflecting inflammation and
destruction in euthyroid Hashimoto’s thyroiditis (HT), we investigated the clinical utilities of the heterogeneity index (HI)
[the coefficient of variance (CV) of the ultrasonographic (US) intensities], focusing on anti-thyroid peroxidase antibodies
(TPO-Ab), which represent not only disease activity but also subsequent thyroid destruction of HT.
Methods: Forty-four consecutive patients with euthyroid HT [60.5 ± 2.7 years old (mean ± SE)] and 30 age-matched
normal controls were studied. HI was calculated as the CV (SD/mean) of US intensities of either four points per lobe of
the thyroid gland along a horizontal line at the depth of the right common carotid artery. Evaluation included serum
levels of free thyroxine (FT4), free triiodothyronine (FT3), thyroid stimulating hormone (TSH), anti-thyroid peroxidase
antibodies (TPO-Ab), anti-thyroglobulin antibodies (Tg-Ab), thyroglobulin and thyroid volume.
Results: While no differences were observed for TSH, FT4 and FT3, thyroglobulin and thyroid volume between the two
groups, HI exhibited a tendency towards a significant difference (3.59 ± 0.20% in HT patients vs 3.23 ± 0.19% in normal
group, p = 0.089). In HT patients, there was a significant and positive correlation of HI with TPO-Ab (r = 0.396, p = 0.034),
whereas such a correlation was absent in normal controls. In both groups, there were no significant correlations of HI
with Tg-Ab, FT3, FT4 or TSH.
Conclusions: This is the first report of the close relation between heterogeneity of US of the thyroid gland and TPO-Ab
in euthyroid HT patients before the heterogeneity becomes distinguishable from normal thyroid glands. Furthermore,
at this stage, subsequent thyroid destruction in HT might be already be predicted through the heterogeniety of the
thyroid tissue.
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Ultrasonographic (US) examination is a very accurate
and highly sensitive method for assessing thyroid gland
lesions, especially thyroid nodules, that can be performed
quickly even in out-patient clinics [1]. Nevertheless, few
studies have reported the use of US to estimate inflamma-
tion and destruction of thyroid parenchymal tissue. While* Correspondence: toshi-n@jg7.so-net.ne.jp
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reproduction in any medium, provided the orhypoechogenicity has been reported in untreated and
levothyroxine-treated overt hypothyroid Hashimoto’s
thyroiditis (HT) patients [2,3], the clinical utility of
measuring US intensities remains unknown in euthyroid
HT without apparent hypoechogenicity.
In the current report, we used a newly-designed sensitive
US method that was able to distinguish from the
hypoechogenicity [2,3] and enabled to assess and quantify
heterogeneity in the euthyroid state, as the heterogeneity
index (HI) [CV of the US intensities of eight points of
thyroid gland on horizontal line between bilateral commonLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of the thyroid gland and weakening of ultrasound because
it was based on the CV (SD/mean) of the US intensities
along a horizontal line.
For patients with HT, a highly sensitive radioimmuno-
assay system for anti-thyroid antibodies [anti-thyroglobulin
antibodies (Tg-Ab) and anti-thyroid peroxidase antibodies
(TPO-Ab)] has proven to be essential for diagnosis [4]. In
particular, TPO-Ab has been established to represent the
current activity of HT and subsequent thyroid destruction,
because the TPO-antigen is closely involved with cell-
mediated cytotoxicity, whereas the Tg-Ab is not [5].
Therefore, we investigated the clinical meaning of HI in
euthyroid HT patients, and attempted to correlate HI with
a variety of thyroid markers, such as thyroid hormones,
thyroglobulin and thyroid volume, and autoimmune
anti-thyroid antibodies.Patients and methods
Subjects
The study was approved by the ethical review committee
of Osaka City University Hospital. Written informed
consent was obtained from each patient. Newly detected
56 HT patients in a euthyroid state (M/F, 10/40) were
enrolled consecutively during the 7-month period from
January to July, 2011.
The diagnosis of HT was made based on the elevation
of either Tg-Ab or TPO-Ab above the normal upper
limit. To confirm sustained euthyroidism, thus excluding
patients with a temporary condition, i.e., during the
recovery from painless thyroiditis or occult subacute
thyroiditis, measurement of TSH was conducted at least
twice over 6 months. Moreover, to avoid confounding
factors known to affect thyroid hormones, patients who
were pregnant or post-partum [6], patients receiving
other hormone-replacement therapy or taking any drugs
that could affect thyroid hormones, such as amiodarone
hydrochloride, interferon and Interleukin-2, lithium
carbonate, gonadotropin releasing hormone, raloxifene
hydrochloride, anti-convulsion drugs, and rifampicin, and
those with autoimmune antibodies, were excluded from
the study [7,8].
Normal control subjects who joined the Health-Check
Program at Osaka City University Hospital were enrolled
consecutively as age-matched controls (M/F, 10/40).
Normal controls had no history of thyroid disease, had
neither goiter nor an autoimmune-antibody titer, and
were in a euthyroid state.
The smoking index (the daily number of cigarettes
multiplied by the number of years of smoking) was
similar between the HT patients and normal controls
and individual smoking habits did not change during
this study.Serum parameters
Blood was drawn just before ultrasonography after over-
night fasting. Commercially available electrochemilumi-
nescent immunoassay (ECLIA) kits were used for the
thyroid hormone assay. TSH was measured by sandwich
ElecsysW, and FT4 and FT3 levels were determined by
competitive ElecsysW (Roche Diagnostics K.K., Tokyo,
Japan) [9]. Anti-thyroglobulin (Cosmic Co., Tokyo, Japan)
and anti-thyroid peroxidase antibodies (Cosmic Co.,
Tokyo, Japan) were also determined using highly-sensitive,
commercially available, radioimmunoassay kits [10]. In
this system, highly purified thyroglobulin and thyroid
peroxidase were used as antigens. Serum concentrations of
anti-thyroglobulin and anti-thyroid peroxidase antibodies
greater than 0.4 and 0.3 U/ml, respectively, were considered
positive. Serum thyroglobulin levels were measured using
an ECLIA kit, ElecsysW (Roche Diagnostics K.K., Tokyo,
Japan) [11].
Quantitative ultrasonographic measurements of
heterogeneity index and thyroid volume
Thyroid HI was determined using an US apparatus
(LOGIQ 7PRO, GE healthcare, Princeton, NJ, USA) with
a 10-MHz linear array probe operating in B-mode
(Figure 1). Four open-circle cursors (2 mm in diameter)
per half lobe were positioned along a horizontal line at
the depth of the right common carotid artery adjacent to
the thyroid gland. US intensity within each circle was
automatically calculated immediately after one cursor
was set. HI was defined as the CV (SD/mean) of eight US
intensities. All measurements were performed by the same
examiner (Y.N.), who was blinded to the characteristics of
the subjects.
Thyroid volume was also determined by ultrasonog-
raphy, based on a calculation using an ellipsoid model
(width × length × thickness × 0.7 for each lobe) [12].
Statistical analysis
Data are expressed as the mean ± SE unless otherwise
indicated. Statistical analyses were performed using
StatView (version 5.0, SAS Institute, Cary, NC). Differences
in clinical factors between HT patients and normal
controls were examined using the Mann–Whitney U
test for assessment of the median values. The difference
in the male/female ratio between the two groups was
analyzed using the chi-square test. Simple regression
analysis was used to examine the relationships between
the two factors. P-values less than 0.05 were considered to
be statistically significant.
Results
Clinical variables in normal controls and HT patients
A comparison of the variables between normal controls
and HT patients is presented in Table 1. In addition to
Figure 1 Recording of the ultrasonographic intensities and calculation of the thyroid heterogeneity index (HI). The appropriate sampling
points were first determined for measuring. Four open-circle cursors (2 mm in diameter) per half lobe were positioned straight along a horizontal
line at the depth of the right common carotid artery adjacent to the thyroid gland. US intensity within each circle was automatically calculated
immediately after the cursor was set. HI was defined as the CV (i.e., SD/mean) of eight US intensities.
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renal function and lipid profiles, no significant differences
were found in age, male/female ratio, BMI, smoking index,
the serum level of TSH, FT3 and FT4, thyroglobulin, or
thyroid volume between normal controls and HT patients
(data not shown).
HI in normal controls and HT patients
As shown in Table 1, HI exhibited a tendency towards a
significant difference between normal controls and HT
patients (3.23 ± 0.19% in the normal group vs. 3.59 ± 0.20%
in the HT patients, p = 0.089).Table 1 Baseline characteristics of the subjects with Hashimo
Subjects with Hashimoto
Number of subjects 44
Gender (female/male) 32/12
Age (years) 60.5 ± 2.7
Body mass index (kg/m2) 21.7 ± 0.48
Smoking index 74 ± 59
Tg-Ab (U/mI) [<0.4] 8.37 ± 2.55
TPO-Ab (U/mI) [<0.3] 15.3 ± 6.13
FT4 (pmol/l) [11.6-21.9] 14.5 ± 0.37
FT3 (pmol/l) [3.54-6.16] 4.17 ± 0.11
TSH (mIU/l) [0.5-5] 2.40 ± 0.33
Thyroglobulin (mg/l) [0.0-30.0] 43.4 ± 20.6
Thyroid volume (mm3) 14687.1 ± 1494.3
HI (%) 3.23 ± 0.19
Data are expressed as the mean ± SE. The differences between two groups were ex
ns: not significant, Systolic BP: systolic blood pressure, Diastolic BP: diastolic blood p
antibody, HI: heterogeneity index.Correlations between HI and clinical variables in normal
controls and HT patients
The correlations between HI and the clinical variables in
normal controls and HT patients are presented in
Table 2. In the HT patients there was a significant and
positive correlation between HI and TPO-Ab (r = 0.396,
p = 0.034) but not Tg-Ab (r = −0.014, p = 0.941) or TSH
(r = −0.012, p = 0.953). In normal controls HI did not
correlate with these factors. There were no significant
correlations between HI and age, BMI, smoking index,
serum level of FT3, FT4, thyroglobulin or thyroid volume
in either group (data not shown).to’s thyroiditis and the controls
’s thyroiditis Normal controls P
44
32/12 ns
58.7 ± 1.9 ns
21.4 ± 0.58 ns
67 ± 72 ns
<0.4
<0.3
14.6 ± 0.57 ns
3.95 ± 0.15 ns
2.53 ± 0.28 ns
40.6 ± 11.5 ns
15757.2 ± 1984.4 ns
3.59 ± 0.20 ns(0.089)
amined using the Mann–Whitney U test for assessment of the medians.
ressure, Tg-Ab; anti-thyroglobulin antibody, TPO-Ab; antithyroid peroxidase
Table 2 Correlations between the heterogeneity index






r P r P
Age (years) 0.077 ns 0.082 ns
Body mass index 0.253 ns 0.201 ns
Smoking index 0.292 ns 0.201 ns
Systolic BP 0.044 ns 0.153 ns
Diastolic BP −0.045 ns 0.279 ns
Pulse rate −0.143 ns −0.017 ns
Tg-Ab −0.014 ns
TPO-Ab 0.396 0.034
FT4 −0.045 ns 0.188 ns
FT3 −0.239 ns −0.048 ns
TSH −0.125 ns −0.172 ns
Thyroglobulin −0175 ns −0.204 ns
Thyroid volume 0.264 ns 0. 175 ns
Data are expressed as the mean ± SE. Simple regression analysis was used.
ns: not significant, Systolic BP: systolic blood pressure, Diastolic BP: diastolic
blood pressure, Tg-Ab; anti-thyroglobulin antibody, TPO-Ab; antithyroid
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Figure 2 Simple regression analysis to determine the correlation of th
(TPO-Ab) (a), anti-thyroglobulin antibody (Tg-Ab) (b), and TSH (c) in H
(r = 0.396, p = 0.034), but not with HI and Tg-Ab or TSH (r = −0.014, p = 0.94
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TPO-Ab, Tg-Ab and TSH in the HT patients.
Discussion
The results of the study revealed a significant and positive
correlation between HI and TPO-Ab in euthyroid HT
patients. In these patients, HI might reflect not only the
extent of current inflammation and destruction of the
thyroid tissue, but also subsequent destruction in HT,
because TPO-Ab is responsible for these changes through
an autoimmune reaction in HT [5]. However, in the cases
with very mild destruction, this correlation likely suggests
the subsequent potential for terminal destruction.
TPO, originally described as thyroid microsomal antigen,
is present on the apical surface of thyroid follicular cells
and is the antigen most closely involved in cell-mediated
cytotoxicity [13]. Hence, among auto-immune antibodies
specific for the thyroid gland, the TPO-Ab titer represents
the degree of lymphocytic infiltration of the thyroid gland,
reflecting the current activity of HT, as well as subsequent
stages in the development of HT [5,13].
Nevertheless, since only a tendency of HI was found
between HT patients and normal controls (Table 1),
inflammation and destruction of the thyroid tissue would
likely be slight or mild in the early phase of HT, namely
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ashimoto’s thyroiditis (HT). HI correlated significantly with TPO-Ab
1 and r = −0.012, p = 0.953, respectively).
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destruction but more likely a measure of the potential for
terminal destruction of the thyroid gland that can be
achieved in the early stages of HT.
In a previous report, an interaction between the HLA-
DRB4 and cytotoxic T-lymphocyte associated antigen 4
(CTLA-4) genes was shown to determine the thyroid
function of TPO-positive Japanese HT patients with
goiter [13]. This is consistent with our findings, supporting
that terminal destruction of thyroid gland is genetically
predisposed.
Meanwhile, Tg-Ab, another auto-immune anti-thyroid
antibody [4], did not correlate with HI in HT patients
(Figure 2). Multiple antigen configurations of thyroglobulin
are produced when it becomes iodinated, resulting in
functionally active but immunologically distinct molecules
[13]. Therefore, changes in Tg-Ab could occur independent
of immune responses or the consequent inflammation
and destruction in HT.
The lack of correlation of HI with FT3, FT4 and TSH in
HT patients (Table 2) might be explained by similar
degrees of heterogeneity and thyroid hormones between
HT patients and normal controls. Thus, in the euthyroid
state of early HT inflammation, the simultaneous destruc-
tion of thyroid tissue had not progressed sufficiently to
affect these factors. If measured in a stage of overt
hypothyroidism, a correlation might be observed between
HI and thyroid hormones, as was reported previously,
with respect to hypoechogenicity in HT [2,3]. This is the
subject of ongoing and future investigations by our group.
Serum thyroglobulin did not correlate with HI in this
study (Table 2). Possible explanations for this are as
follows: although thyroglobulin is intimately associated
with the thyroid, it is a normal component of the blood, as
some thyroglobulin is invariably secreted, during normal
thyroid hormone release [14]. Therefore, the elevation of
serum thyroglobulin in HT could be due to increased leak
in response to TSH stimulation or the excessive production
by the associated cancer. Moreover, problems include
variable sensitivity and reproducibility of the assays and
interference by thyroglobulin autoantibodies [15]. Hence,
in the euthyroid state the existence of Tg-Ab thyroglobu-
lin may be of less clinical importance.
HI did not correlate with thyroid volume (Table 2),
likely due to the same reason of the early stage of HT; i.e.,
in the presence of a very mild inflammation and early
destruction of thyroid tissue in the euthyroid state of
HT, the changes in thyroid volume did not reach statistical
significance. In another previous investigation of overt
autoimmune hypothyroidism, thyroid volume correlated
negatively with echogenicity [16].
HI is easily and reproducibly obtained using ultrasonog-
raphy, and is not affected by the depth of the thyroid
gland and weakening of ultrasound, because it representsthe CV (SD/mean) of US intensities along a horizontal
line.
Thus, computerized grey-scale analysis using US was
previously reported to be useful in quantifying thyroid
hypoechogenicity in untreated and levothyroxine-treated
overt hypothyroid HT patients [7]. The marked difference
from our method is not in the assessment of heterogeneity
but in the quantification of hypoechogenicity, which
would be affected by the depth of the thyroid gland and
weakening of the ultrasound. Furthermore, while their
subjects included untreated and levothyroxine-treated
overt hypothyroid HT patients, our method was applied
to euthyroid and subclinical hypothyroid patients with
visually indistinguishable heterogeneity.
Further, computerized grey-scale analysis allows for signifi-
cant correlations between hypoechogenicity and indices of
the thyroid gland, namely serum TSH, FT4 and TPO-Ab
values. Interestingly, even in overt hypothyroidism
echogenicity did not correlate with Tg-Ab, but rather cor-
related with TPO-Ab, possibly due to the same underlying
reasons noted above.
One limitation of HI is obstruction by the tumor or cyst
along the horizontal line for sampling, which interferes
with positioning of the four open-circle cursors for each
half lobe. Another limitation occurs when the thyroid
gland is too small or atrophic, and cursors cannot be
positioned properly. Since each open-circle is 2 mm in
diameter, a straight line more than 8 mm in length is
needed for each lobe.
In summary, our results demonstrate the close relation
between heterogeneity of the thyroid gland and TPO-Ab
in euthyroid and subclinical hypothyroid patients with
Hashimoto’s thyroiditis. It was suggested that even in
such hormonal states, without distinguishable inflamma-
tion or destruction of thyroid tissue compared with
normal subjects, subsequent thyroid destruction of HT
might already be indicated through heterogeniety of the
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